FDA.reportPublic FDA data

nevirapine

Product NDC
69097-233
11-digit product format
690970233
Labeler code
69097
Product ID
69097-233_d8c3e274-100e-4526-84a2-ef541b415d4e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
nevirapine
Dosage form
SUSPENSION
Route
ORAL
Labeler
Cipla USA Inc.
Application
ANDA207684
Marketing category
ANDA
Marketing start
2017-08-03
Marketing end
0000-00-00
Substance
NEVIRAPINE HEMIHYDRATE
Active strength
50 mg/5mL
Pharmacologic classes
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69097-233-442025-12-22C16284748780-19d75b9cf-e891-f424-e053-dadaa90a57ced1e92221-5e02-4ed9-b53e-d83bbbd07944
69097-233-462025-12-22C16284748780-19d75b9cf-e891-f424-e053-dadaa90a57ced1e92221-5e02-4ed9-b53e-d83bbbd07944
69097-233-442020-01-31C16284748780-19d75b9cf-e891-f424-e053-dadaa90a57ced1e92221-5e02-4ed9-b53e-d83bbbd07944
69097-233-462020-01-31C16284748780-19d75b9cf-e891-f424-e053-dadaa90a57ced1e92221-5e02-4ed9-b53e-d83bbbd07944

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69097-233NEVIRAPINE SUSPENSION [CIPLA USA INC.]6Legacy NDC20181218_d1e92221-5e02-4ed9-b53e-d83bbbd07944.zip